Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P. - Wikidata - awgldk - TriplyDB

Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P.

Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P.

http://www.wikidata.org/entity/Q35787045

about

Bone marrow fibrosis in myelofibrosis: pathogenesis, prognosis and targeted strategies Host responses in tissue repair and fibrosis Bone marrow-derived fibrocytes contribute to liver fibrosis The phenotypic fate and functional role for bone marrow-derived stem cells in liver fibrosis Distinct types of fibrocyte can differentiate from mononuclear cells in the presence and absence of serum Contribution of bone marrow-derived fibrocytes to liver fibrosis Serum amyloid P therapeutically attenuates murine bleomycin-induced pulmonary fibrosis via its effects on macrophages The role of fibrocytes in sickle cell lung disease.The role of fibrocytes in fibrotic diseases of the lungs and heart Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts A serum amyloid P-binding hydrogel speeds healing of partial thickness wounds in pigs.Serum amyloid P inhibits fibrosis through Fc gamma R-dependent monocyte-macrophage regulation in vivo.Polycythemia Vera Management and Challenges in the Community Health Setting.Inhibition of murine fibrocyte differentiation by cross-linked IgG is dependent on FcγRI Circulating progenitor cells and scleroderma Serum amyloid P inhibits dermal wound healing.Monocyte development inhibitor PRM-151 decreases corneal myofibroblast generation in rabbits High and low molecular weight hyaluronic acid differentially regulate human fibrocyte differentiation.Improved serum-free culture conditions for spleen-derived murine fibrocytes.Toll-like receptor 2 agonists inhibit human fibrocyte differentiation.NaCl potentiates human fibrocyte differentiation Reactive response of fibrocytes to vocal fold mucosal injury in rat Medical therapy of stricturing Crohn's disease: what the gut can learn from other organs - a systematic review.Detection of alveolar fibrocytes in idiopathic pulmonary fibrosis and systemic sclerosis Fibroblasts secrete Slit2 to inhibit fibrocyte differentiation and fibrosis.Trypsin potentiates human fibrocyte differentiation.Cigarette smoke exacerbates mouse allergic asthma through Smad proteins expressed in mast cells.Persistent lung inflammation and fibrosis in serum amyloid P component (APCs-/-) knockout mice The long pentraxin PTX3 promotes fibrocyte differentiation Adenosine A2A receptor blockade or deletion diminishes fibrocyte accumulation in the skin in a murine model of scleroderma, bleomycin-induced fibrosis.Smoking and idiopathic pulmonary fibrosis Brain serum amyloid P levels are reduced in individuals that lack dementia while having Alzheimer's disease neuropathology.DC-SIGN activation mediates the differential effects of SAP and CRP on the innate immune system and inhibits fibrosis in mice Circulating fibrocytes are increased in children and young adults with pulmonary hypertension.Histochemical Detection of Collagen Fibers by Sirius Red/Fast Green Is More Sensitive than van Gieson or Sirius Red Alone in Normal and Inflamed Rat Colon Galectin-3 Binding Protein Secreted by Breast Cancer Cells Inhibits Monocyte-Derived Fibrocyte Differentiation.Caveolin-1 signaling in lung fibrosis.TNF-α-stimulated fibroblasts secrete lumican to promote fibrocyte differentiation FcγRI mediates serum amyloid P inhibition of fibrocyte differentiation

P2860

Q26744113-3E2DB154-B8B8-412C-A84E-8EF3DA6A3A95 Q26852800-1D1DB7F5-3C88-4421-8393-BAB58DDA2168 Q27021576-54C591D1-FA53-49A8-8D66-8E30B1A6DFC0 Q27026037-C0F0734E-7B88-400C-BF9C-81E3D4DCDC69 Q27332359-E6784B6B-AB5F-498C-A94C-2DA49E8862F1 Q28083363-23E15427-073D-435A-A011-5E4CDB2EA083 Q28748540-8D62AD5B-19C2-4C07-8ADA-E11109C21925 Q30427773-39CA62D8-BC75-4277-AF22-42B53934A973 Q30433418-8EEE1679-0272-4C84-BC0A-836EA4DAC566 Q30435304-46997371-07F5-4025-BFF3-62FF8D5C139C Q33510941-5902E744-8EBB-4683-AD83-99612ED37E1E Q33772501-26E099A0-11EF-4779-9AE2-6E6DFD8C51A3 Q33782308-6F0418C0-4D0E-4E3D-A221-B9BE938134CE Q33803036-0C20A6A2-EF8E-474A-8586-E6C4DC2B0301 Q33911638-E7E533D4-D60E-4CE2-9CF3-00061193B99B Q33989134-B5C5CCD0-7FB5-4176-939B-BF73A88A0718 Q34013195-8CD2B171-3EDE-4DE5-8CBB-F5CEA1F33644 Q34024768-FBF28857-3402-4786-A772-43F133D10643 Q34055945-D840FC30-FB85-4C9F-9D0E-C14237C5F0FB Q34380533-8DC1E5D2-03F8-4FF2-BB1E-E10605B3DD4E Q34408050-6D2BD6D9-C75F-417F-877E-84A42D4F0312 Q34429781-2A772E83-8462-42DD-BC66-9C96DF000C06 Q34494156-12C61F21-8600-4B9D-938A-DBBEC8200761 Q34504710-F4CFC5EB-CD6B-4634-8A50-2BB2F89529C9 Q34558662-BAB708A8-07FE-4DDF-B5DB-4FE7BB284537 Q34793502-8630611F-605E-4C90-AFB7-AA5CDD47CEE9 Q34947713-46A45334-B669-43F7-9BD0-4A57EF2B5B7F Q34995061-283532E7-4ADE-4386-B140-650E02FF98CA Q35138521-C5039850-4626-49EF-AE99-EE0908EEEDE7 Q35182082-B93FEEC3-5B95-460C-8686-8AD43DB1A591 Q35190917-61C99428-3CD1-4CCF-8136-2154ACC7A638 Q35788811-6BBE2A69-5524-41C9-A489-095921CAA376 Q35823366-B2BBAF97-F13B-40CF-BDD7-F23F2DD0D2F1 Q35845691-008AA6C8-3589-4AC4-9643-1BFC653AD795 Q35869442-CF059C07-8D53-482D-99CD-F651007146CD Q35870335-35C91DED-25BC-4A85-8902-6B4C59EEA3D7 Q35931701-4CEC8470-1F05-4828-806F-5D71D3FEEF21 Q36093857-22357AFE-3FAA-48A1-87F4-F503A5A226AA Q36103058-0C8AD954-2A47-4DD6-9D4A-9E26334C4241 Q36232242-8D5E126E-99D4-40CC-BC30-BF1177953CAA

P2860

Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P.

http://www.wikidata.org/entity/Q35787045

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P.

@ast

Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P.

@en

type

label

Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P.

@ast

Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P.

@en

prefLabel

Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P.

@ast

Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P.

@en

P1433

Q35787045-DD654973-6060-47CD-BE3C-C00B3AB6F314

P1476

Q35787045-6017D1CD-739E-4AF1-8EEA-0DD27AD12C97

P2093

Q35787045-512323D8-3DCE-471A-8368-444570DA96AB

Q35787045-B3F255B6-48D8-4083-AB21-7A0E5083768E

Q35787045-BBA90B7F-7B2B-4B1A-BF1A-AF026A295B07

Q35787045-E0D20819-9472-416D-AD02-1B69498A74E1

Q35787045-E115DC9A-10C4-42B5-ACEA-091F0D05A152

P2860

Q35787045-06BB9E97-AE56-4206-95CD-515B1C827F35

Q35787045-07FBA01E-D167-4781-A91F-A84479426D9D

Q35787045-15C6188F-014A-461E-8809-F3A22974E156

Q35787045-16504770-8F5B-4425-B51A-09C9690BD82F

Q35787045-1B21C2B0-4708-4E43-BF96-D96803DBF5ED

Q35787045-26B32DA6-BAA9-427F-A56A-67139D098303

Q35787045-29CFD211-0442-44B3-B4C4-633CC9B5E97D

Q35787045-2A3C88E8-8B29-43EB-9DD6-BF17CBAA2DCA

Q35787045-301A8A34-B890-44D8-9F45-54EF76F2D424

Q35787045-3DC9CC9E-9726-40F7-8CAD-999EB32E9AD8

P304

Q35787045-85008088-90EE-4532-9219-3B792B5840E2

P31

Q35787045-E2EAAF0A-BBE1-471B-8559-A46615D3377E

P356

Q35787045-F26F03A5-DB02-4361-8065-B41DC4C11238

P407

Q35787045-CCDFA6C0-59FB-4FA8-83E7-73056FB82C3A

P433

Q35787045-64DBC791-E384-44D8-BAB0-2953373EF078

P478

Q35787045-64A83AFB-933D-489E-AE09-E348F9C100A4

P50

Q35787045-2F3C7242-1EE7-4130-8075-BD29665CF91D

Q35787045-FC1FD73E-C304-4D20-B684-D3E9D380FEFE

P577

Q35787045-9EA62A68-F890-4EB3-9B8A-B953069AB66F

P5875

Q35787045-A472E913-E4AB-471E-8893-302E2AF559AD

P698

Q35787045-FBE47DA4-4506-4E2A-874B-AB63128590F2

P921

Q35787045-0F9E5289-43DE-49E2-8511-1C7FC671BC45

P932

Q35787045-4E6E1D5B-1AD0-4509-9803-1F0CB7DD36D4

P356

JIMMUNOL.179.6.4035

P1433

Journal of Immunology

P1476

Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P

@en

P2093

David Roife

http://www.w3.org/2001/XMLSchema#string

Elizabeth L Travis

http://www.w3.org/2001/XMLSchema#string

Jeff R Crawford

http://www.w3.org/2001/XMLSchema#string

Min Wang

http://www.w3.org/2001/XMLSchema#string

Sanna D Ronkainen

http://www.w3.org/2001/XMLSchema#string

P2860

Human serum amyloid P component is a single uncomplexed pentamer in whole serum

Inhibition of fibrocyte differentiation by serum amyloid P

Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis

Isolation and characterization of C-reactive protein and serum amyloid P component in the rat

Control of autofluorescence of archival formaldehyde-fixed, paraffin-embedded tissue in confocal laser scanning microscopy (CLSM).

Human serum amyloid P component protects against Escherichia coli O157:H7 Shiga toxin 2 in vivo: therapeutic implications for hemolytic-uremic syndrome.

C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction.

Regulation of phagocytic leukocyte activities by C-reactive protein.

Serum amyloid P component binds to Fc gamma receptors and opsonizes particles for phagocytosis.

Peripheral blood fibrocytes from burn patients: identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells.

P304

4035-4044

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.179.6.4035

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

179

http://www.w3.org/2001/XMLSchema#string

P50

Richard H Gomer

Darrell Pilling

P577

2007-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6054365

http://www.w3.org/2001/XMLSchema#string

P698

17785842

http://www.w3.org/2001/XMLSchema#string

P921

pulmonary fibrosis

P932

4482349

http://www.w3.org/2001/XMLSchema#string